Literature DB >> 22814721

The role of innate immunity in HBV infection.

Qiuju Han1, Cai Zhang, Jian Zhang, Zhigang Tian.   

Abstract

Hepatitis B virus (HBV) infection is one of the main causes of chronic liver diseases. Whether HBV infection is cleared or persists is determined by both viral factors and host immune responses. It becomes clear that innate immunity is of importance in protecting the host from HBV infection and persistence. However, HBV develops strategies to suppress the antiviral immune responses. A combined therapeutic strategy with both viral suppression and enhancement of antiviral immune responses is needed for effective long-term clearance and cure for chronic HBV infection. We and others confirmed that bifunctional siRNAs with both gene silencing and innate immune activation properties are beneficial for inhibition of HBV and represent a potential approach for treatment of viral infection. Understanding the nature of liver innate immunity and their roles in chronic HBV progression and HBV clearance may aid in the design of novel therapeutic strategies for chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814721     DOI: 10.1007/s00281-012-0331-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  161 in total

1.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

Authors:  Eric T T L Tjwa; Gertine W van Oord; Joost P Hegmans; Harry L A Janssen; Andrea M Woltman
Journal:  J Hepatol       Date:  2010-09-06       Impact factor: 25.083

Review 2.  Kinetics of the immune response during HBV and HCV infection.

Authors:  Antonio Bertoletti; Carlo Ferrari
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

3.  Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B.

Authors:  Zheng Zhang; Dawei Chen; Jinxia Yao; Hui Zhang; Lei Jin; Ming Shi; Hongfei Zhang; Fu-Sheng Wang
Journal:  Clin Immunol       Date:  2006-10-18       Impact factor: 3.969

4.  Epidemic of hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells.

Authors:  A S Tripathy; R Das; M S Chadha; V A Arankalle
Journal:  J Viral Hepat       Date:  2011-05-18       Impact factor: 3.728

5.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.

Authors:  Dylan Burdette; Adam Haskett; Lance Presser; Steven McRae; Jawed Iqbal; Gulam Waris
Journal:  J Gen Virol       Date:  2011-10-12       Impact factor: 3.891

7.  Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.

Authors:  E Seki; H Tsutsui; H Nakano; N Tsuji; K Hoshino; O Adachi; K Adachi; S Futatsugi; K Kuida; O Takeuchi; H Okamura; J Fujimoto; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

8.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

10.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  18 in total

Review 1.  Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.

Authors:  Jieliang Chen; Zhenghong Yuan
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

Review 2.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

Review 3.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

4.  Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection.

Authors:  Sukriti Sukriti; Nirupma Trehanpati; Manoj Kumar; Chandana Pande; Syed S Hissar; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2016-09-22       Impact factor: 6.047

5.  Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation.

Authors:  S K Nissen; J F Højen; K L D Andersen; E Kofod-Olsen; R K Berg; S R Paludan; L Østergaard; M R Jakobsen; M Tolstrup; T H Mogensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.

Authors:  Quan Yuan; Liu-Wei Song; Daniela Cavallone; Francesco Moriconi; Beatrice Cherubini; Piero Colombatto; Filippo Oliveri; Barbara Agata Coco; Gabriele Ricco; Ferruccio Bonino; James Wai Kuo Shih; Ning-Shao Xia; Maurizia Rossana Brunetto
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 7.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.

Authors:  Cheng Sun; Hao-yu Sun; Wei-hua Xiao; Cai Zhang; Zhi-gang Tian
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

8.  Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells.

Authors:  Hongjun Peng; Mei Shi; Li Zhang; Yuanyuan Li; Jing Sun; Lirong Zhang; Xiaohui Wang; Xiaopeng Xu; Xiaolei Zhang; Yijie Mao; Yun Ji; Jingting Jiang; Weifeng Shi
Journal:  BMC Microbiol       Date:  2014-06-07       Impact factor: 3.605

9.  The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice.

Authors:  Yoshinobu Yokoyama; Takuya Miyagi; Hayato Hikita; Teppei Yoshioka; Kaori Mukai; Takatoshi Nawa; Ryotaro Sakamori; Kazuyoshi Ohkawa; Naoki Hiramatsu; Takeshi Takahashi; Hiroshi Suemizu; Akihide Ryo; Tomohide Tatsumi; Tetsuo Takehara
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a.

Authors:  Zhaohua Hou; Jian Zhang; Qiuju Han; Chenhe Su; Jing Qu; Dongqing Xu; Cai Zhang; Zhigang Tian
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.